(Q46755906)

24 December 2017

title

Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis (English)

1 reference

24 December 2017

1 reference

9

Edward K Geissler

1 reference

24 December 2017

author name string

Stefan Farkas

1

1 reference

24 December 2017

Matthias Hornung

2

1 reference

24 December 2017

Christine Sattler

3

1 reference

24 December 2017

Markus Guba

4

1 reference

24 December 2017

Markus Steinbauer

5

1 reference

24 December 2017

Matthias Anthuber

6

1 reference

24 December 2017

Hans Herfarth

7

1 reference

24 December 2017

Hans J Schlitt

8

1 reference

24 December 2017

publication date

14 October 2005

1 reference

24 December 2017

International Journal of Colorectal Disease

published in

1 reference

24 December 2017

volume

21

1 reference

24 December 2017

issue

8

1 reference

24 December 2017

page(s)

747-753

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00384-005-0793-7

exact match

0 references

cites work

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

1 reference

12 December 2020

Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis

1 reference

12 December 2020

Antiadhesion molecule therapy in inflammatory bowel disease

1 reference

12 December 2020

Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides

1 reference

12 December 2020

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

12 December 2020

Benefit-risk assessment of sirolimus in renal transplantation

1 reference

12 December 2020

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer

1 reference

12 December 2020

An improved intravital microscopy system.

1 reference

12 December 2020

Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension

1 reference

12 December 2020

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 reference

12 December 2020

The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy

1 reference

12 December 2020

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy

1 reference

12 December 2020

Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression

1 reference

12 December 2020

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

1 reference

12 December 2020

Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy

1 reference

12 December 2020

Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients

1 reference

12 December 2020

Conversion to sirolimus in solid organ transplantation: a Single-Center experience

1 reference

12 December 2020

Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients

1 reference

12 December 2020

Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity

1 reference

12 December 2020

Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies

1 reference

12 December 2020

Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin

1 reference

12 December 2020

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

1 reference

12 December 2020

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

12 December 2020

Cyclosporin for refractory ulcerative colitis

1 reference

12 December 2020

Effect of cyclosporin A on cell adhesion molecules and leukocyte-endothelial cell interactions in experimental colitis.

1 reference

12 December 2020

Recurrence of bronchioloalveolar carcinoma in transplanted lungs

1 reference

12 December 2020

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

12 December 2020

Cardiovascular toxicities of immunosuppressive agents

1 reference

12 December 2020

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

12 December 2020

Post-transplant malignancy: the role of immunosuppression

1 reference

12 December 2020

Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients

1 reference

12 December 2020

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

12 December 2020

Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus

1 reference

12 December 2020

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

1 reference

12 December 2020

Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease

1 reference

12 December 2020

Microcirculation in inflammatory bowel diseases

1 reference

12 December 2020

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

12 December 2020

Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

1 reference

12 December 2020

Intravenous cyclosporin in ulcerative colitis: a five-year experience

1 reference

12 December 2020

Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future

1 reference

12 December 2020

Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients

1 reference

12 December 2020

Some problems with posttransplant lymphoproliferative disease

1 reference

12 December 2020

The mechanism of action of cyclosporin A and FK506

1 reference

12 December 2020

Effect of cyclosporine in a murine model of experimental colitis.

1 reference

12 December 2020

Quantification of mucosal leucocyte endothelial cell interaction by in vivo fluorescence microscopy in experimental colitis in mice

1 reference

12 December 2020

Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice

1 reference

12 December 2020

Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis

1 reference

12 December 2020

Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow"

1 reference

12 December 2020

10.1007/S00384-005-0793-7

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017